Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Prostatic Neoplasms 4Breast Neoplasms 4Neoplasms 3Leiomyoma 2Vomiting 1Polycystic Ovary Syndrome 1Peripheral Nervous System Diseases 1Periampullary Carcinoma Nos 1Pediatric Crohn's disease 1Pain 1Obesity 1Nausea 1Myasthenia Gravis 1Motor Activity 1Menstruation Disturbances 1Memory Disorders 1Hyperinsulinism 1Hyperandrogenism 1Hot Flashes 1Fatigue 1Cognitive Dysfunction 1Cancer Pain 1Anemia 1

Interventions

Exercise 9Metformin 2tislelizumab 1Vitamin D 1Tea 1Surveys and Questionnaires 1Sugars 1Resistance Training 1Probiotics 1Oxaliplatin 1Nutrition Assessment 1Leucovorin 1Fluorouracil 1Fish Oils 1Diet, Mediterranean 1Diet Therapy 1Diet 1Curcumin 1Counseling 1Capecitabine 1Caloric Restriction 1Andrographis paniculata extract 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Motor Activity × Sugars × Clear all
NCT01697566 2025-06-11

An Endometrial Cancer Chemoprevention Study of Metformin

M.D. Anderson Cancer Center

Phase 3 Completed
29 enrolled 12 charts
Other

Hyperinsulinism, Motor Activity, Obesity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡